Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 130-138 , May 2005

Molecular Signature Analysis: Using the Myocardial Transcriptome as a Biomarker in Cardiovascular Disease

  • Michelle M. Kittleson
    • ,
  • Joshua M. Hare

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Joshua M. Hare, MD, Johns Hopkins Hospital, Ross 1059, 720 Rutland Avenue, Baltimore, MD, 21287. Tel.: (+1) 410-614-4161; fax: (+1) 443-287-7945

References 

  1. Ardehali H, Qasim A, Cappola T, et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am. Heart J. 2004;147:919–923
  2. Barrans JD, Allen PD, Stamatiou D, et al. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am. J. Pathol. 2002;160:2035–2043
  3. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J. Am. Coll. Cardiol. 2003;41:1096–1106
  4. Boheler KR, Volkova M, Morrell C, et al. Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc. Natl. Acad. Sci. USA. 2003;100:2754–2759
  5. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 2004;350:1605–1616
  6. Carey VJ, Gentry J, Whalen E, Gentleman R. Network structures and algorithms in Bioconductor. Bioinformatics. 2005;21:135–136
  7. Chaitman BR, Pepine CJ, Parker JO, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. JAMA. 2004;291:309–316
  8. Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108:1432–1439
  9. Chen Y, Park S, Li Y, et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol. Genomics. 2003;14:251–260
  10. Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ. Res. 2002;91:559–564
  11. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 2004;351:2159–2169
  12. DePrimo SE, Wong LM, Khatry DB, et al. Expression profiling of blood samples from an SU5416 phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer. 2003;3:3
  13. Dudoit S, Gentleman RC, Quackenbush J. Open source software for the analysis of microarray data. Biotechniques. 2003;(Suppl):45–51
  14. Felker GM, Hu W, Hare JM, et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore). 1999;78:270–283
  15. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000;342:1077–1084
  16. Hall JL, Grindle S, Han X, et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol. Genomics. 2004;17:283–291
  17. Holleman A, Cheok MH, Den Boer ML, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med. 2004;351:533–542
  18. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation. 2004;110:3815–3821
  19. Hwang JJ, Allen PD, Tseng GC, et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics. 2002;10:31–44
  20. Kaab S, Barth AS, Margerie D, et al. Global gene expression in human myocardium–oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J. Mol. Med. 2004;82:308–316
  21. Kittleson MM, Ye SQ, Irizarry RA, et al. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation. 2004;110:3444–3451
  22. Kittleson MM, Minhas KM, Irizarry RA, et al. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics. 2005;21:299–307
  23. Kittleson MM, Minhas KM, Irizarry RA, et al. Gene expression in giant cell myocarditis: altered expression of immune response genes. Int. J. Cardiol. 2005;(in press)
  24. Liu ET, Karuturi KR. Microarrays and clinical investigations. N. Engl. J. Med. 2004;350:1595–1597
  25. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 2004;350:1828–1837
  26. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J. Card. Fail. 2002;8:S500–S505
  27. Margulies KB, Matiwala S, Cornejo C, et al. Mixed messages. Transcription patterns in failing and recovering human myocardium. Circ. Res. 2005;1–8
  28. Mirotsou M, Watanabe CMH, Schultz PG, et al. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol. Genomics. 2003;15:115–126
  29. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 2004;351:2817–2826
  30. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002;346:1937–1947
  31. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer. Inst. 2003;95:14–18
  32. Steenman M, Chen YW, Le Cunff M, et al. Transcriptomal analysis of failing and nonfailing human hearts. Physiol. Genomics. 2003;12:97–112
  33. Steenman M, Lamirault G, Le Meur N, et al. Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur. J. Heart. Fail. 2005;7:157–165
  34. Tan FL, Moravec CS, Li J, et al. The gene expression fingerprint of human heart failure. Proc. Natl. Acad. Sci. USA. 2002;99:11387–11392
  35. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA. 2002;99:6567–6572
  36. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA. 2001;98:5116–5121
  37. Twine NC, Stover JA, Marshall B, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer. Res. 2003;63:6069–6075
  38. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 2004;350:1617–1628
  39. Van De Vijver MJ, He YD, Van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002;347:1999–2009
  40. Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004;83:281–297

 This research was supported by National Institutes of Health grant 5RO1-HL-065455 (JMH). JMH is a recipient of a Paul Beeson Physician Faculty Scholars in Aging Research Award. MMK is a recipient of the Pearl M. Stetler Research Fund for Women Physicians Fellowship Award.

PII: S1050-1738(05)00061-7

doi: 10.1016/j.tcm.2005.05.007

Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 130-138 , May 2005

Article Tools

* Image Usage & Resolution